I like British drug giant GlaxoSmithKline
Glaxo did, however, deliver another solid quarter of performance. Global sales rose 9% in constant currency terms, with operating profits up 13% and margins up slightly. Standbys like Advair and Avandia continue to do well, and newer drugs like Coreg and Valtrex are still growing.
Since Glaxo talked a bit about the impact of Medicare Part D on the pharmaceutical industry, I figure I'll chip in my two cents as well. It's certainly true that the government entitlement program will give the elderly better access to medications and that this could provide a short-term boost in several drug categories. Over the long haul, though, I'm not sure it's such a boon. Giving UnitedHealth
Be that as it may (or may not), Glaxo at least has a good pipeline going for it. Or perhaps I should add "in theory." After all, until the FDA says yes and your drug is on the shelves behind the counter at Walgreen, you just never really know. So while the company's DPP-IV inhibitor Redona (just to pick one) may be great -- and a serious threat to Novartis
As I said in the opening paragraph, Glaxo is a basically dependable company that just isn't tremendously cheap. Then again, there aren't too many cheap pharma stocks left nowadays -- unless you want a riskier situation, like say, Pfizer
For more pharm-fresh Foolishness:
GlaxoSmithKline and Merck are both Motley Fool Income Investor recommendations, while Pfizer and UnitedHealth are Motley Fool Inside Value picks. UnitedHealth is also a recommendation in our Motley Fool Stock Advisor service. You can try any of our services free for 30 days, with no obligation to buy.
Fool contributor Stephen Simpson has no financial interest in any stocks mentioned (that means he's neither long nor short the shares).
More from The Motley Fool
Why Bitcoin Loans Are About to Explode
Find out why a budding new industry just got a big boost.
The Top 3 Financial Resolutions for 2018 -- and How to Succeed at Them
Most vow-makers fail at their resolutions, but here are some strategies that can help you succeed.
5 Reasons the IRS May Take Away Your Tax Refund
Don't lose your next tax refund to the IRS.